Different Effects of the ABCG2 C.421C>A SNP on the Pharmacokinetics of Fluvastatin, Pravastatin and Simvastatin

Keskitalo, Jenni E, Pasanen, Marja K, Neuvonen, Pertti J, Niemi, Mikko·2009·Pharmacogenomics
DOI 10.2217/pgs.09.85

Cited by (189)

Items 101–189 of 189

  1. Effects of Polymorphisms in NR1H4, NR1I2, SLCO1B1, and ABCG2 on the Pharmacokinetics of Rosuvastatin in Healthy Chinese Volunteers
    Mei Liu, Xiujun Wu, Gui-Lian Zhao, Ti Zhang, Shansen Xu, Ya‐Xin Sun, Feng Qiu, Limei Zhao · 2016 · Journal of Cardiovascular Pharmacology
  2. Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers
    Shingen Misaka, Osamu Abe, Hideyuki Sato, Tomoyuki Ono, Yayoi Shikama, Satomi Onoue, Hirooki Yabe, Junko Kimura · 2018 · European Journal of Clinical Pharmacology
  3. Pediatric Pharmacogenomics
    Jonathan B. Wagner, James Steven Leeder · 2012 · Pediatric Clinics of North America
  4. Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins
    Luna Prieto Garcia, Anna M. Vildhede, Pär Nordell, Christine Ahlström, Ahmed B. Montaser, Tetsuya Terasaki, Hans Lennernäs, Erik Sjögren · 2024 · CPT Pharmacometrics & Systems Pharmacology
  5. Transporter genesABCG2rs2231142 andABCB1rs1128503 polymorphisms and atorvastatin response in Chilean subjects
    Yalena Prado, Tomás Zambrano, Luis Antonio Salazar · 2017 · Journal of Clinical Pharmacy and Therapeutics
  6. Impacts of ABCG2 loss of function variant (p. Gln141Lys, c.421 C > A, rs2231142) on lipid levels and statin efficiency: a systematic review and meta-analysis
    Yang Liu, Yuan Chen, Baozhu Wei, Hang Li, Yuanyuan Peng, Zhi Luo · 2024 · BMC Cardiovascular Disorders
  7. Effect of Roxadustat on the Pharmacokinetics of Simvastatin, Rosuvastatin, and Atorvastatin in Healthy Subjects: Results From 3 Phase 1, Open‐Label, 1‐Sequence, Crossover Studies
    Dorien Groenendaal‐van de Meent, Martin den Adel, Virginie Kerbusch, Jan van Dijk, Tomohisa Shibata, Kota Kato, Marloes P. Schaddelee · 2022 · Clinical Pharmacology in Drug Development
  8. Potential role of the ABCG2-Q141K polymorphism in type 2 diabetes
    Edit Szabó, Anna Kulin, Orsolya Mózner, Laszlo I Koranyi, Botond Literáti-Nagy, Márta Vitai, Judit Cserepes, Balázs Sarkadi, György Várady · 2021 · PLoS ONE
  9. Studying the right transporter at the right time: an in vitro strategy for assessing drug-drug interaction risk during drug discovery and development
    Robert Elsby, Hayley Atkinson, Philip J. Butler, Robert J. Riley · 2022 · Expert Opinion on Drug Metabolism & Toxicology
  10. BCRP/ABCG2 Transporter Regulates Accumulation of Cadmium in Kidney Cells: Role of the Q141K Variant in Modulating Nephrotoxicity
    Xia Wen, Danielle Kozlosky, Ranran Zhang, Cathleen Doherty, Brian Buckley, Emily S. Barrett, Lauren M. Aleksunes · 2021 · Drug Metabolism and Disposition
  11. Modulation of Phospholipid Bilayer Properties by Simvastatin
    Ruijie D. Teo, D. Peter Tieleman · 2021 · The Journal of Physical Chemistry B
  12. Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report
    Henriette E. Meyer zu Schwabedissen, Werner Siegmund, Heyo K. Kroemer, Jens Dieter Rollnik · 2014 · BMC Research Notes
  13. Simvastatin intolerance genetic determinants: some features in ethnic Uzbek patients with coronary artery disease
    Aleksandr B. Shek, Ravshanbek D. Kurbanov, Guzal J. Abdullaeva, Aleksandr V. Nagay, Shavkat U. Hoshimov, Ulugbek I. Nizamov, Зияева Адолат Васиковна, Rano B. Alieva · 2017 · Archives of Medical Science - Atherosclerotic Diseases
  14. The rs1142345 in TPMT Affects the Therapeutic Effect of Traditional Hypoglycemic Herbs in Prediabetes
    Xi Li, Fengmei Lian, Dong Guo, Lan Fan, Jie Tang, Jingbo Peng, Hong‐Wen Deng, Zhaoqian Liu, Xinhua Xiao, Yan-Rong Wang et al. · 2013 · Evidence-based Complementary and Alternative Medicine
  15. Association of SLCO1B1*1b with peptic ulcer amongst Japanese patients taking low-dose aspirin
    Akiko Shiotani, Takahisa Murao, Takashi Sakakibara, Ken‐ichi Tarumi, Noriaki Manabe, Tomoari Kamada, Hiroaki Kusunoki, Ken Haruma · 2011 · Digestive and Liver Disease
  16. A case of simvastatin‐induced myopathy with SLCO1B1 genetic predisposition and co‐ingestion of linagliptin and Stevia rebaudiana
    Jones Chun Man Chan, Ming‐Him Ng, Raymond S. M. Wong, Brian Tomlinson · 2019 · Journal of Clinical Pharmacy and Therapeutics
  17. Relevance of Breast Cancer Resistance Protein to Pharmacokinetics of Florfenicol in Chickens: A Perspective from In Vivo and In Vitro Studies
    Yang Liu, Li Guo, Mire Zloh, Yujuan Zhang, Jinhu Huang, Liping Wang · 2018 · International Journal of Molecular Sciences
  18. Utilizing Large Electronic Medical Record Data Sets to Identify Novel Drug–Gene Interactions for Commonly Used Drugs
    Mustafa Adnan Malki, Adem Y. Dawed, Caroline Hayward, Alex S. F. Doney, Ewan R. Pearson · 2021 · Clinical Pharmacology & Therapeutics
  19. Towards Safer and More Predictable Drug Treatment – Reflections from Studies of the First BCPT Prize Awardee
    Pertti J. Neuvonen · 2012 · Basic & Clinical Pharmacology & Toxicology
  20. Genetic and ethnic modulation of cardiovascular toxicity of vascular endothelial growth factor inhibitors
    Yen‐Chou Chen, Cheng‐Chih Chung, Yung‐Kuo Lin, Yi‐Jen Chen · 2017 · Annals of Medicine
  21. Impact of Q141K on the Transport of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors by ABCG2
    Yutaka Inoue, Takashi Morita, Mari Onozuka, Ken-ichi Saito, Kazumi Sano, K. Hanada, Masami Kondo, Yoichi Nakamura, Tohru Kishino, Hiroshi Nakagawa et al. · 2019 · Cells
  22. Genetic polymorphisms associated with adverse reactions of molecular-targeted therapies in renal cell carcinoma
    Kazuhiro Yamamoto, Ikuko Yano · 2018 · Medical Oncology
  23. SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population
    Punyabhorn Rattanacheeworn, Monpat Chamnanphon, Siriwan Thongthip, Wonngarm Kittanamongkolchai, Natavudh Townamchai, Yingyos Avihingsanon, Udomsak Udomnilobol, Thomayant Prueksaritanont, Suree Jianmongkol, Pajaree Chariyavilaskul · 2020 · Pharmacogenomics and Personalized Medicine
  24. Identification of Genetic Variants Associated with Pravastatin and Pitavastatin Pharmacokinetics
    Anssi J. H. Mykkänen, E. Katriina Tarkiainen, Suvi Taskinen, Mikko Neuvonen, Maria Paile‐Hyvärinen, Tuomas Olavi Lilius, Tuija Tapaninen, Janne T. Backman, Aleksi Tornio, Mikko Niemi · 2025 · Clinical Pharmacology & Therapeutics
  25. Approach to Clinical and Genetic Characterization of Statin-Induced Myopathy
    QiPing Feng · 2014 · Methods in molecular biology
  26. Co-administration of Fluvastatin and CYP3A4 and CYP2C8 Inhibitors May Increase the Exposure to Fluvastatin in Carriers of CYP2C9 Genetic Variants.
    Yuji Mukai, Masayuki Narita, Erika Akiyama, K. Ohashi, Yasutaka Horiuchi, Yuka Kato, T. Toda, A. Rane, N. Inotsume · 2017 · Biological and Pharmaceutical Bulletin
  27. Statins as adjuvants in the treatment of ovarian cancer: Controversy and misunderstanding
    Natalia Manzano‐León, Patricia García‐López · 2021 · European Journal of Pharmacology
  28. ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population
    Tamara Božina, Lana Ganoci, Ena Karačić, Livija Šimičević, Majda Vrkić Kirhmajer, Iva Klarica Domjanović, Tena Križ, Zrinka Sertić, Nada Božina · 2022 · Annals of Human Biology
  29. Role of Pharmacogenetics on Response to Statins: A Genotype-based Approach to Statin Therapy Outcome
    İpek Duman · 2014 · Journal of Cardiology and Therapy
  30. Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients
    Sarah Allegra, Jessica Cusato, Silvia De Francia, Filomena Longo, Elisa Pirro, Davide Massano, Valeria Avataneo, Amedeo De Nicolò, Antonio Giulio Piga, Antonio D’Avolio · 2018 · Pharmacogenetics and Genomics
  31. Simvastatin enhances the efficacy of nilotinib in chronic myeloid leukaemia by post-translational modification and drug transporter modulation
    Kartini Asari, Wen Tian Sun, Ze Hui Kok, Yi Hui Lam, Bee Ling Ng, Verity A Saunders, Deborah L. White, Charles T. H. Chuah, Wei Xiang · 2021 · Anti-Cancer Drugs
  32. Impacts of Pharmacokinetic Gene Polymorphisms on Steady‐State Plasma Concentrations of Simvastatin in Thai Population
    Sayanit Tipnoppanon, Udomsak Udomnilobol, Sarawut Siwamogsatham, Yongkasem Vorasettakarnkij, Chonlaphat Sukasem, Thomayant Prueksaritanont, Pajaree Chariyavilaskul, Varalee Yodsurang, Thanate Srimatimanon, Monpat Chamnanphon et al. · 2025 · Clinical and Translational Science
  33. Relationship between CYP2C8, UGT1A1, and ABCG2 gene polymorphisms and the exposure, efficacy, and toxicity of eltrombopag in the treatment of refractory aplastic anemia
    Wei Zuo, Bo Liu, Miao Chen, Bo Zhang, Bing Han · 2022 · European Journal of Clinical Pharmacology
  34. Nanomolar therapeutic concentrations of statins rapidly induce cerebral artery vasoconstriction by stimulating L-type calcium channels
    Farzana Zerin, Nazia Hoque, Sreelakshmi N. Menon, Emmanuella Ezewudo, Nimi P. Simon, Samira Sooreni, Mashmum S. Shahid, Morgan Jones, Ajay Pandey, Yasin Gökçe et al. · 2025 · Biochemical Pharmacology
  35. The inhibitory effect of simvastatin and aspirin on histamine responsiveness in human vascular endothelial cells
    Mais Absi, Jason I.E. Bruce, Donald T. Ward · 2014 · American Journal of Physiology-Cell Physiology
  36. Genetic Determinants of Response to Statins in Cardiovascular Diseases
    Ghazaleh Ghorbannezhad, Shima Mehrabadi, Negar Golampour-Shamkani, Amir Hossein Barjasteh, Poorya Etesamizadeh, Mohammad Tayyebi, Majid Khazaei, Seyed Mahdi Hassanian, Gordon A. Ferns, Amir Avan · 2024 · Current Cardiology Reviews
  37. Association Between ABCG2 Polymorphism and Statin-Induced Adverse Events: A Meta-Analysis
    Da Hoon Lee, Hae Ji Shin, Beom Yoon, Han Wool Kim, Heui Sug Jo, Hee Jung Kim, Woorim Kim · 2025 · Cardiovascular Toxicology
  38. In Vivo Characterization of Interactions on Transporters
    Hiroyuki Kusuhara, Kenta J. Yoshida, Yuichi Sugiyama · 2013 · AAPS advances in the pharmaceutical sciences series
  39. Potential clinical significance of statins on methicillin resistance reversion in Staphylococcus aureus
    Jesús Machuca, María Carmen Conejo, Álvaro Pascual, José Manuel Rodríguez-Martínez · 2021 · Enfermedades Infecciosas y Microbiología Clínica
  40. Pharmacogenomics in cardiovascular diseases
    Maroof Ahmed, Bashir Ahmad Malla, Umer Majeed Khaja, Aashiq Hussain Bhat, Aarif Ali, Showkat Ahmad Ganie, Muneeb U. Rehman, Zuha Imtiyaz · 2023 · Elsevier eBooks
  41. Excretory Processes in Toxicology: Drug Transporters in Drug Development
    KP. Van Ness, EJ Kelly · 2017 · Elsevier eBooks
  42. Statin Muscle Toxicity and Genetic Risk Factors
    Giuliana Germana Mombelli · 2013 · International Journal of Genomic Medicine
  43. Breast Cancer Resistance Protein (BCRP) or ABCG2
    Agnès Basseville, Robert W. Robey, Julian C. Bahr, Susan Elaine Bates · 2014
  44. ADME Pharmacogenomics in Drug Development
    Liangfu Chen, Joseph W. Polli · 2013
  45. Pharmacokinetics and lipid-lowering efficacy affected by polymorphisms in genetic variability in statin therapy
    Muneshwar Rajput, Saliha Rizvi, Pushpendra D. Pratap, Syed Tasleem Raza, Zeba Siddiqi, Vineeta Khare · 2025 · Egyptian Journal of Medical Human Genetics
  46. Lipid-lowing pharmacogenomics in Chinese patients
    Miao Hu, Brian Tomlinson · 2013 · Expert Review of Cardiovascular Therapy
  47. Potential clinical significance of statins on methicillin resistance reversion in Staphylococcus aureus
    Jesús Machuca, María Carmen Conejo, Álvaro Pascual, José Manuel Rodríguez-Martínez · 2022 · Enfermedades infecciosas y microbiologia clinica (English ed )
  48. Genetic Marker of Statin-induced Rhabdomyolysis
    Kan Chiba, Kaori Morimoto · 2011 · YAKUGAKU ZASSHI
  49. Screening study for genetic polymorphisms affecting pharmacokinetics of simvastatin
    Sohee Im, Bo‐Hyung Kim, Kidong Lee, KyuBum Kwack, Sung‐Vin Yim · 2016 · Translational and Clinical Pharmacology
  50. Creatine Kinase as a Biomarker
    Lígia Moriguchi Watanabe, Marcela Augusta de Souza Pinhel, Natália Yumi Noronha, Carla Barbosa Nonino · 2022 · Biomarkers in disease
  51. BCRP (ABCG2)
    Agnès Basseville, Susan Elaine Bates, William Douglas Figg, Alex Sparreboom · 2013
  52. Transport of statins by multidrug resistance-associated proteins 1 and 5
    Suvi-Kukka Tuomi, Feng Yu Deng, Mikko Neuvonen, Mikko Niemi · 2025 · European Journal of Pharmaceutical Sciences
  53. Pharmacogenomic Mechanisms of Drug Toxicity
    Shiew Mei Huang, Ligong Chen, Kathleen M. Giacomini · 2012 · Elsevier eBooks
  54. Drug Transporters: Efflux
    Eliza R. McColl, Vessela Vassileva, Micheline Piquette‐Miller · 2021 · Elsevier eBooks
  55. ABCG2, THE BREAST CANCER RESISTANCE PROTEIN (BCRP)
    Robert W. Robey, Sabrina Lusvarghi, Cindy H. Chau, Agnès Basseville, William Douglas Figg, Suresh V. Ambudkar, Susan Elaine Bates · 2022
  56. The Genetic Blueprint of Cardiovascular Therapy: Pharmacogenomics for Improved Efficacy and Safety
    Nikhilesh Andhi, Bhuvana Darawadi · 2024 · Journal of Indian College of Cardiology
  57. Predicting nifedipine responses in preterm labor: a risk score incorporating ABCG2 polymorphisms and clinical factors
    Jung Sun Kim, Ji Min Han, Jeong Yee, Young Ju Kim, Suk‐Joo Choi, Hye Sun Gwak · 2025 · Pharmacogenomics
  58. Screening study for genetic polymorphisms affecting pharmacokinetics of pioglitazone
    Ji Young Yun, Bo‐Hyung Kim, Ji Hyun Lee, Kidong Lee, KyuBum Kwack, Sung‐Vin Yim · 2016 · Translational and Clinical Pharmacology
  59. Evaluation of Food Effects on the Oral Pharmacokinetics of Rosuvastatin
    Cheynne McLean · 2016 · Scholarship@Western (Western University)
  60. Bioequivalence Study of Two Formulations of Simvastatin 20 mg Tablet in Healthy Filipino Participants under Fasting Conditions: A Randomized, Open-label, Two-way Crossover Study
    Rita Grace Y. Alvero, Rea Carmela C. Aquino, BSc, Aline S Balmadrid, Geraldo P. Balaccua · 2023 · Acta Medica Philippina
  61. Breast cancer resistance protein (BCRP)/ABCG2
    Yurong Lai · 2013 · Elsevier eBooks
  62. The Association between Genetic Polymorphisms and Simvastatin-Induced Myopathy: A Narrative Synthesis of Evidence
    Xingang Li, Shusen Sun, Xiaowei Xu, Zhigang Zhao, Wei Li · 2018 · Drug Research
  63. Polymorphisms of Drug Transporters and Clinical Relevance
    Aparna Chhibber, Janine Micheli, Deanna L. Kroetz · 2014 · Wiley eBooks
  64. New genetic markers for treatment personalization in pediatric Acute Lymphoblastic Leukemia
    Elixabet López-López · 2013 · Communities in ADDI (University of the Basque Country)
  65. Drug Metabolism, Transport, and Pharmacogenomics
    Kristina Wolf, Brandon T. Gufford, Scott J. Brantley, Paul Brent Watkins, Mary F. Paine · 2015 · Yamada's Textbook of Gastroenterology
  66. Cardiovascular Disease Pharmacogenomics
    Bishwanath Chatterjee · 2013 · Springer eBooks
  67. Pharmacokinetic interactions and pharmacogenetics of aliskiren
    Tuija Tapaninen · 2012 · Työväentutkimus Vuosikirja
  68. Regulatory Perspective on Pharmacogenomics of Drug‐Metabolizing Enzymes and Transporters
    Lei Zhang, Gilbert J. Burckart, Lawrence J. Lesko, Shiew Mei Huang · 2013
  69. ADME of Cardiovascular Drugs
    Hong Shu Liu, Richard L. Voorman · 2012 · Encyclopedia of Drug Metabolism and Interactions
  70. Statin-Induced Muscle Toxicity
    QiPing Feng, Russell A. Wilke · 2012 · Elsevier eBooks
  71. [Role of breast cancer resistance protein in drug disposition].
    Xiangmeng Wu, Sheng Li, Yufei Jia, Yan Li · 2016 · PubMed
  72. Transport of statins by human ABC efflux transporters in vitro
    Suvi-Kukka Tuomi · 2021 · UTUPub (University of Turku)
  73. Introduction to prostate cancer metabolism and treatment with nonconventional drugs
    Tomas Koltai, Stephan J. Reshkin, Fátima Baltazar, Larry Fliegel · 2021 · Elsevier eBooks
  74. The Effect of Pre-eclampsia and HIV on the Expression and Regulation of Drug Transporters in Placenta
    Dea Kojovic · 2021 · TSpace (University of Toronto)
  75. Impact of Intestinal Efflux Transporters on Oral Absorption
    Ayman F. El‐Kattan · 2017
  76. Stroke Pharmacogenetics
    Lauren Elizabeth Walker, Anna Stewart, Munir Pirmohamed · 2017 · Springer eBooks
  77. Stroke Pharmacogenetics
    Lauren Elizabeth Walker, Anna Stewart, Munir Pirmohamed · 2012 · Springer eBooks
  78. Creatine Kinase as a Biomarker
    Lígia Moriguchi Watanabe, Marcela Augusta de Souza Pinhel, Natália Yumi Noronha, Carla Barbosa Nonino · 2022 · Biomarkers in disease
  79. Simvastatin therapy in different subtypes of hypercholesterolemia – a physiologically based modelling approach
    Florian Bartsch, Jan Grzegorzewski, Helena Leal Pujol, Hans‐Michael Tautenhahn, Matthias König · 2023 · medRxiv
  80. DISTRIBUTION OF POLYMORPHISMS OF GENES OF STATINS METABOLISM AND TRANSPORT IN THE LIVER IN PATIENTS WITH CORONARY ARTERY DISEASE ETHNIC UZBEKS WITH SIMVASTATIN INTOLERANCE
    Aleksandr B. Shek, Ravshanbek D. Kurbanov, G. J. Abdullayeva, A. V. Nagai, Alisher A. Abdullaev, Ш С Ахмедова, Shavkat U. Hoshimov, Зияева Адолат Васиковна · 2017 · Eurasian heart journal
  81. Excretory Processes in Toxicology: Drug Transporters in Drug Development
    Brad Christopher Hansen, Kirk P. Van Ness, Edward J. Kelly · 2024 · Elsevier eBooks
  82. Stroke Pharmacogenetics
    Lauren Elizabeth Walker, Anna Stewart, Munir Pirmohamed, James Frederick Meschia, Frances Bartlett Kinne · 2024 · Springer eBooks
  83. Assessment of Potential Drug–Drug Interactions for Novel Oral Melanocortin‐1 Receptor Agonist Dersimelagon
    Akihito Ogasawara, Ryosuke Ide, Shinsuke Inoue, Minoru Tsuda, Renli Teng · 2025 · Pharmacology Research & Perspectives
  84. Additional file 1 of Impacts of ABCG2 loss of function variant (p. Gln141Lys, c.421 C > A, rs2231142) on lipid levels and statin efficiency: a systematic review and meta-analysis
    Liu, Yang, Chen, Yuan, Baozhu Wei, Li, Hang, Peng, Yuanyuan, Luo, Zhi · 2024 · Figshare
  85. Additional file 2 of Impacts of ABCG2 loss of function variant (p. Gln141Lys, c.421 C > A, rs2231142) on lipid levels and statin efficiency: a systematic review and meta-analysis
    Liu, Yang, Chen, Yuan, Baozhu Wei, Li, Hang, Peng, Yuanyuan, Luo, Zhi · 2024 · Figshare
  86. Additional file 3 of Impacts of ABCG2 loss of function variant (p. Gln141Lys, c.421 C > A, rs2231142) on lipid levels and statin efficiency: a systematic review and meta-analysis
    Liu, Yang, Chen, Yuan, Baozhu Wei, Li, Hang, Peng, Yuanyuan, Luo, Zhi · 2024 · Figshare
  87. Rifampin-induced fluvastatin toxicity: a case report and review of literature
    Ahmed Farghali, Hossameldin Abdalla Ahmed Mahmoud, M. R. SALEM · 2026 · Oxford Medical Case Reports
  88. Current knowledge in pharmacogenomics and precision medicine: perspectives of the PGRN global PGx committee on improving drug therapies in underrepresented ethnic populations
    Mohamed Nagy, Gerard Marshall Raj, Rekha Priyadarshini, Luis A. Quiñones, Amit Mitra, Lay Kek Teh, Aniwaa Owusu Obeng, Ben L. Kong, Folefac Aminkeng, Collen Mutowembwa Masimirembwa et al. · 2026 · Pharmacogenomics
  89. Pharmacogenomics in Drug Metabolizing Enzymes and Transporters
    Jochen Maas, Roland Wesch, Dietmar Weitz · 2013 · Springer eBooks